文档介绍:现代肿瘤医学 2021年 08月 第 29卷第 15期 MODERNONCOLOGY,Aug.2021,VOL29,No15 ·2741·
2012,150(2):389-401. ZHANGBH,YUEHY.Newmethodsincancerresearch[J].Med
[28] 张百红,岳红云.肿瘤研究的新方法学[J].西北国防医学杂 JNDFNC,2016,37(2):117-120. (编校:张黛妮)
志,2016,37(2):117-120.
PD-1/PD-L1抑制剂治疗晚期卵巢癌的研究进展
李一鑫,路 丹
ResearchprogressofPD-1/PD-L1inhibitorinthetreatmentofadvancedovarian
cancer
LIYixin,LUDan
DepartmentofOncology,SecondAffiliatedHospitalofHarbinMedicalUniversity,HeilongjiangHarbin150000,China.
【Abstract】Ovariancancerisoneofthemostcommontypesofgynecologicalmalignanttumors.Becausethereareno
obvioussymptomsintheearlystage,thepatientsareadvancedatthetimeoftreatment.Atpresent,thestandardtreat
mentofadvancedovariancancerismainlyplatinum-basedchemotherapy,butmostpatientswillhaverecurrenceor
post-drugresistance.Therefore,thereisanurgentneedfornewtreatmentstoimprovetheprognosisofpatientswith
advancedovariancancer.Inrecentyears,withthein-depthstudyoftumorimmunologyandmolecularbiology,immu
notherapy,asanewwaytotreattumors,providesanewtreatmentdirectionforpatientswithadvancedovariancancer.
Thisarticlereviewstheclinicalresearchstatusofimmunotherapyforadvancedovariancancer.
【Keywords】advancedovariancancer,im